• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Wright Medical extends federal deferred prosecution deal by a year

Wright Medical extends federal deferred prosecution deal by a year

September 15, 2011 By MassDevice staff

Wright Medical

Wright Medical Group Inc. (NSDQ:WMGI) said it agreed to extend a deferred prosecution agreement with federal prosecutors today, who accused the orthopedic device maker of running a kickbacks scheme drive up implant sales.

Wright agreed in October 2010 to pay nearly $8 million to settle charges that it ran a kickbacks scheme to drive up sales of its hip and knee implants. The feds had charged the Arlington, Tenn.-based company with using consulting gigs for physicians to funnel alleged kickbacks to the docs. The settlement also included a year-long probation of sorts, during which the AG agreed not to prosecute as long as Wright toed the line.

That apparently didn’t happen; in May, prosecutors accused Wright of violating the terms of their deal. Today the company said it agreed to extend its de facto probation for another year, until Sept. 29, 2012, via an addendum to its DPA with the U.S. Attorney’s Office for New Jersey.

Sign up to get our free newsletters delivered right to your inbox

Wright, which earlier today revealed plans to lay off about 6 percent of its workforce, also said federal authorities don’t plan to bar it from federal health care programs unless prosecutors "were to take further action related to an alleged breach of the DPA."

"Wright Medical and our board of directors have taken significant steps to enhance the company’s compliance," chairman and interim CEO David Stevens said in prepared remarks. "We believe that voluntarily extending the term of the DPA will provide the Company with an opportunity to further demonstrate its commitment to the highest standards of ethical conduct. We will continue to work closely with the Monitor, the USAO, the OIG and other regulators to ensure that the Company complies with all laws and regulations that govern our business practices."

"Our Office is pleased with the extensive cooperation from the newly appointed interim senior management team. Today’s extension will allow Wright to make the transition from interim to permanent senior management while still under the terms of the DPA and the surveillance of the federal monitor." First Assistant U.S. Attorney J. Gilmore Childers said.

In April, a surprise shakeup in Arlington saw the abrupt resignation – without severance – of former CEO Gary Henley and the outright firing of CTO Frank Bono, who was discharged “for failing to exhibit appropriate regard for the company’s ongoing compliance program.” Three other senior executives resigned the next month.

Speculation was rife at the time that the shakeup was due to last year’s $8 million settlement and the revelation by Wright of an internal probe that found “credible evidence of serious wrongdoing,” according to regulatory filings. The next day, the company said, the feds sent a reply alleging that Wright “knowingly and willfully committed at least two breaches of material provisions of the DPA.”

Filed Under: Legal News, News Well, Orthopedics Tagged With: wrightmedical

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy